Search research articles
Contact Us
Filters
Showing results (181-190 of 290) with videos related to
Page
of 29
Sort By:
Inflammatory Bowel Diseases
|
February 2, 2017
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
Subrata Ghosh, Edouard Louis, Laurent Beaugerie, et al.
Gastroenterology
|
February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study
Peter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
BMJ Open Gastroenterology
|
February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Edouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research
|
April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Gastroenterology
|
July 10, 2002
NOD2/CARD15 does not influence response to infliximab in Crohn's disease
Severine Vermeire, Edouard Louis, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
November 2, 2024
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort
Catherine Reenaers, Diana Enea, Marie Nachury, et al.
Journal of Crohn'S & Colitis
|
June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
Marc Ferrante, Brian G Feagan, Julián Panés, et al.
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 290) with videos related to
Sort By:
Page
of 29
Inflammatory Bowel Diseases
|
February 2, 2017
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases
Subrata Ghosh, Edouard Louis, Laurent Beaugerie, et al.
Gastroenterology
|
February 26, 2026
The effect of dose-intensification after secondary loss of response to ustekinumab in Crohn's disease: Results of the REScUE study
Peter Bossuyt, Jean-Francois Rahier, Filip Baert, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
BMJ Open Gastroenterology
|
February 15, 2022
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
Edouard Louis, Kristine Paridaens, Sameer Al Awadhi, et al.
Intestinal Research
|
April 15, 2022
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, et al.
Gastroenterology
|
July 10, 2002
NOD2/CARD15 does not influence response to infliximab in Crohn's disease
Severine Vermeire, Edouard Louis, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
November 2, 2024
Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort
Catherine Reenaers, Diana Enea, Marie Nachury, et al.
Journal of Crohn'S & Colitis
|
June 2, 2021
Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
Marc Ferrante, Brian G Feagan, Julián Panés, et al.
Scandinavian Journal of Gastroenterology
|
December 21, 2021
Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis
Axel U Dignass, Kristine Paridaens, Sameer Al Awadhi, et al.
Page
of 29